http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1268708-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-80
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-58
filingDate 1969-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1972-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1268708-A
titleOfInvention Acylation process
abstract 1,268,708. Acylation process. PFIZER Inc. 8 May, 1969 [23 Jan., 1969], No. 23618/69. Heading C2A. An improved process for the preparation of compounds of the formulae and the pharmaceutically acceptable salts thereof, wherein R 3 is hydrogen, hydroxy, or acetoxy, R 1 is thienyl, furyl, pyridyl, phenyl, or substituted phenyl, wherein the substituent is (lower)alkyl, chloro, bromo, (lower)alkoxy, di(lower)alkylamino or trifluoromethyl; wherein "lower" denotes from 1 to 6 carbon atoms, and R 2 is phenyl or substituted phenyl wherein the substituent is at least one of chloro, bromo, fluoro, (lower)- alkyl, (lower)alkoxy, (lower)alkanoyl, carbo(lower)alkoxy, nitro, or di(lower)alkyl amino; wherein "lower" denotes from 1 to 6 carbon atoms; furyl quinolyl methyl substituted quinolyl phenazinyl 9,10-anthraquinolyl phenanthrenequinolyl anthracenyl phenanthryl (1,3-benzodioxylyl) 3-(2-methyl-4-pyronyl) 3-(4-pyronyl) or N-(methylpyridyl); wherein Y 2 is -CR=CH-O-- -CH=CH-S-- -CH 2 -CH 2 -S- -CH=N-CH=-CH- -CH=CH-CH =CH- -C(O)-CH=CH-C(O)-or -C(O)-C(O)-CH=CH-; wherein Z<SP>1</SP> is -(CH 2 ) 3 - or -(CH 2 ) 4 -, and substituted derivatives thereof wherein the substituent is methyl, chloro or bromo; benzyl, or substituted benzyl wherein the substituent is chloro, bromo, fluoro, (lower)alkyl, (lower)- alkoxy, (lower)alkanoyl, carbo(lower) alkoxy, nitro, or di(lower) alkylamino; wherein "lower" denotes from 1 to 6 carbon atoms; phthalimidomethyl benzohydryl trityl cholesteryl; alkenyl having up to 8 carbon atoms; alkynyl having up to 8 carbon atoms; (1 -indanyl)methyl (2-indanyl)methyl furylmethyl pyridylmethyl (2-pyrrolidono)methyl (4-imidazolyl)methyl [2,2-di(lower alkyl)-1,3-dioxolon-4-yl]methyl cycloalkyl and (lower alkyl) substituted cycloalkyl having from 3 to 7 carbon atoms in the cycloalkyl moiety; and "lower" denotes from 1 to 6 carbon atoms; bicyclo[4. 4 .0]decyl thujyl fenchyl isofenchyl 7-adamantanyl ac-indanyl and substituted derivatives thereof wherein the substituent is methyl, chloro or bromo; ac-tetrahydronaphthyl and substituted derivatives thereof wherein the substituent is methyl, chloro or bromo; alkyl and substituted C 1 -C 6 alkyl wherein the substituent is at least one of: chloro bromo fluoro nitro carbo (C 1 -C 6 alkoxy) C 1 -C 6 alkanoyl C 1 -C 6 alkoxy, or cyano; -CH 2 -CH 2 -NR 5 R 6 -CH 2 -CH 2 -CH 2 -NR 5 R 6 -CH 2 -CH(CH 3 )-NR 5 R 6 or -CH(CH 3 )-CH 2 -NR 5 R 6 wherein -NR 5 R 6 is -NH(C 1 -C 6 alkanoyl), groups may be alike or different; and -N(C 1 - C 6 alkyl)anilino; and -(lower alkylene)-Y 1 wherein (lower alkylene) contains from 1 to 3 carbon atoms; and Y<SP>1</SP> is azetidino aziridino pyrrolidino piperidino morpholino thiomorpholino N-(C 1 -C 6 alkyl) piperazino pyrrolo imidazolo 2-imidazolino 2,5-dimethylpyrrolidino 1,4,5,6 -tetrahydropyrimidino 4-methylpiperidino or 2,6-dimethylpiperidino; which comprises (a) reacting at a temperature of from - 10‹ to 50‹ C. in a reaction-inert solvent, an aryl-malonic acid half-ester having the formula wherein R 1 and R 2 are as defined above, with hexachlorocyclotriphosphatriazine or hexabromocyclotriphosphatriazine, and (b) thereafter reacting the product thus produced with an amino acid compound having the formulae or the alkali metal, alkaline earth metal, or amine salts thereof, wherein R 3 is as defined above, at a temperature of from - 10‹ to 50‹ C. in a reaction-inert solvent at a pH of from 5 to 9.
priorityDate 1969-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 50.